High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activity-Reference-Cited by-同舟云学术

High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activity

Published:2015-05-31 Issue:11 Volume:36 Page:8491-8497
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Devetzoglou Maria,Vyzoukaki Rodanthi,Kokonozaki Maria,Xekalou Athina,Pappa Constantina A.,Papadopoulou Anastasia,Alegakis Athanasios,Androulakis Nikolaos,Alexandrakis Michael G.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-015-3586-9.pdf

Reference31 articles.

1. Kyle RA, Child JA, Anderson K, et al. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121(5):749–75.

2. Sezer O, Jakob C, Euker J, et al. Serum levels of the angiogenic cytokines basic fibroblast grow factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma. Eur J Haematol. 2001;66:83–8.

3. Giuliani N, Storti P, Bolzoni M. Angiogenesis and multiple myeloma. Cancer Microenviron. 2011;4:325–37.

4. Bellamy WT. Expression of vascular endothelial growth factor and its receptors in multiple myeloma and other hematopoietic malignancies. Sesmin Oncol. 2001;28:551–9.

5. De Souza Jr DA, Toso VD, Campos MR, et al. Expression of mast cell proteases correlates with mast cell maturation and angiogenesis during tumor progression. PLoS One. 2012;7:e40790.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a novel cuproptosis‐related gene signature for multiple myeloma diagnosis;Immunity, Inflammation and Disease;2023-11

2. A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple Myeloma;Cancers;2023-09-13

3. Developing mRNA signatures as a novel prognostic biomarker predicting high risk multiple myeloma;Frontiers in Oncology;2023-02-23

4. Genetic analysis of potential biomarkers in cuproptosis from multiple myeloma;2023-01-09

5. Mast cell density and its clinical relevance in Waldenström's macroglobulinemia;eJHaem;2022-02-08